Business Context and Reporting Period
This Form 8-K filing by LifeStance Health Group, Inc. (LFST) reports corporate governance changes effective August 19, 2025. The report covers the resignation of a director and the subsequent appointment of a new director to the Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: William Miller resigned from the Board and all committees effective immediately on August 19, 2025. The resignation was not due to any disagreement with the Company.
- Director Appointment: Sarah Personette was appointed as a director on August 20, 2025.
- Compensation: Ms. Personette received an initial award of 74,766 restricted stock units (RSUs) under the 2021 Equity Incentive Plan. Vesting is subject to time-and performance-based terms and continued service.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on operations, or specific risk factors beyond the standard disclosure of the director transition.
Investor Verification Checklist
- Verify the specific vesting schedule and performance metrics attached to Sarah Personette's 74,766 RSU award.
- Confirm the effective date of William Miller's departure and any potential impact on board committee composition.
- Review the Company's 2021 Equity Incentive Plan to understand the dilution impact of the new grant.